- Home
- SANG vs RGC Comparison
SANG vs RGC Comparison
Compare SANG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- RGC
- Stock Information
- Founded
- SANG 1984
- RGC 2014
- Country
- SANG Canada
- RGC Hong Kong
- Employees
- SANG N/A
- RGC N/A
- Industry
- SANG Computer Software: Programming Data Processing
- RGC Medicinal Chemicals and Botanical Products
- Sector
- SANG Technology
- RGC Health Care
- Exchange
- SANG Nasdaq
- RGC Nasdaq
- Market Cap
- SANG 170.7M
- RGC 171.1M
- IPO Year
- SANG 2021
- RGC 2021
- Fundamental
- Price
- SANG $5.48
- RGC $6.02
- Analyst Decision
- SANG Buy
- RGC
- Analyst Count
- SANG 2
- RGC 0
- Target Price
- SANG $5.63
- RGC N/A
- AVG Volume (30 Days)
- SANG 11.5K
- RGC 26.0K
- Earning Date
- SANG 09-18-2024
- RGC 10-25-2024
- Dividend Yield
- SANG N/A
- RGC N/A
- EPS Growth
- SANG N/A
- RGC N/A
- EPS
- SANG N/A
- RGC N/A
- Revenue
- SANG $247,284,000.00
- RGC N/A
- Revenue This Year
- SANG N/A
- RGC N/A
- Revenue Next Year
- SANG $3.05
- RGC N/A
- P/E Ratio
- SANG N/A
- RGC N/A
- Revenue Growth
- SANG N/A
- RGC N/A
- 52 Week Low
- SANG $2.18
- RGC $3.03
- 52 Week High
- SANG $6.40
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- SANG 55.77
- RGC 46.56
- Support Level
- SANG $5.15
- RGC $5.05
- Resistance Level
- SANG $6.38
- RGC $7.24
- Average True Range (ATR)
- SANG 0.27
- RGC 0.78
- MACD
- SANG 0.06
- RGC -0.03
- Stochastic Oscillator
- SANG 47.66
- RGC 50.52
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable Internet protocol communications systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes Cloud Services, Video Conferencing, Carrier Services, Business Phone Systems, Phones & Devices, and Network Connectivity. The company sells into three major geographic centers: the United States of America, which is the key revenue driver, Canada, and other foreign countries.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.